Activities per year
Activities
- 1 - 50 out of 245 results
Search results
-
Which Are the Best Tyrosine Kinase Inhibitors for Newly Diagnosed Chronic Myelogenous Leukemia?
Hughes, T. (Speaker)
30 May 2025 → 3 Jun 2025Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Novartis Launch Meeting: 'Leading the CML Revolution’
Hughes, T. (Invited speaker)
10 Jun 2025Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
'Embarking on a new journey with Scemblix’ Meeting
Hughes, T. (Speaker)
23 Apr 2025Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Characterization & Efficacy of Tern-701 in pre-clinical models of Chronic Myeloid Leukemia.
Hughes, T. (Invited speaker)
12 Jun 2025 → 15 Jun 2025Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
New discoveries that will shape future therapies in Chronic Myeloid Leukemia
Hughes, T. (Speaker)
2 Mar 2025 → 29 Mar 2025Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Debate 1 – CML - Asciminib first line?
Hughes, T. (Invited speaker)
7 Mar 2025 → 9 Mar 2025Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
'CML Elevate Clinic' Event
Hughes, T. (Invited speaker)
29 Apr 2025 → 30 Apr 2025Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
CML Connect Meeting with Chang Gung Memorial Hospital Lankou - Novartis Taiwan
Hughes, T. (Speaker)
24 Apr 2025Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Omega-3 and Preterm Birth: From Clinical Trials to Real-World Implementation
Best, K. (Speaker)
2025Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Tyrosine kinase inhibitor-responsive chronic myeloid leukaemia is associated with reduced OXPHOS capacity and mtDNA mutations likely contribute to this.
Pagani, I. (Speaker)
15 May 2024 → 17 May 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
ASC4FIRST, a pivotal phase 3 study of asciminib (ASC) vs investigator-selected tyrosine kinase inhibitors (IS TKIs) in newly diagnosed patients (pts) with chronic myeloid leukemia (CML): Primary results.
Hughes, T. (Invited speaker)
31 May 2024 → 4 Jun 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Scientific Exchange: The Disconnect Between Basic and Clinical Research
White, D. (Speaker)
2 Sept 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Transcriptomic analysis reveals the intricacies of Ph+ ALL: Examining gene expression patterns and deletions in relation to patient prognosis.
White, D. (Speaker)
27 Sept 2024 → 29 Sept 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Embedding an Omega-3 Test-and-Treat Program into Routine Antenatal Care to Prevent Preterm Birth
Best, K. (Speaker)
2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
The PoppiE Study - A Decentralised Approach to Perinatal Research.
Best, K. (Speaker)
2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Clinical Spotlight Presentation - Chronic Myeloid Leukaemia: Next Challenges
Hughes, T. (Speaker)
4 Mar 2024 → 5 Mar 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Therapy-related myeloid neoplasm: when genetics collide with environment
Hiwase, D. (Invited speaker)
4 Mar 2024 → 6 Mar 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Healthcare of the Future
White, D. (Keynote speaker)
5 Jul 2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Omega-3 to Reduce Preterm Birth – from Clinical Trials to Implementation
Best, K. (Speaker)
2024Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Evaluating an Omega-3 Test-and-Treat Program, as Part of Routine Pregnancy Care, to Prevent Preterm Birth
Northcott, C. (Speaker)
15 Sept 2023Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Translating Research into Clinical Practice: Implementation of an Omega-3 Test-and-Treat Program into Routine Antenatal Care
Northcott, C. (Speaker)
30 Nov 2023Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Omega-3 Test-and-Treat Program
Northcott, C. (Speaker)
18 Aug 2023Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Resolving Unresolved Neurodevelopmental Disorders
Gecz, J. (Invited speaker)
2022Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
CEIH Improvement Showcase, Improvement Enabled by Technology
Makrides, M. (Speaker)
19 May 2022Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Translational Research Symposium
Makrides, M. (Speaker)
1 Jul 2022Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
PCDH19 clustering epilepsy, disorder of cellular mosaics.
Gecz, J. (Invited speaker)
2022Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Epi and Genetic Determinants of the Variability in CLinical Expressivity
Gecz, J. (Invited speaker)
2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Timing meals and macronutrients: impacts on insulin and clocks
Heilbronn, L. (Invited speaker)
11 Aug 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Time restricted eating – challenges in translation
Heilbronn, L. (Invited speaker)
20 Jul 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Mechanisms Underlying Bladder Sensation in Health and Disease
Grundy, L. (Speaker)
10 Sept 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Why good trials fail and other bumps in the road?
Best, K. (Speaker)
30 Jul 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
ESH INTERNATIONAL JOHN GOLDMAN RESEARCH AWARD 2019: PRESENTATION OF RESULTS. Sunday, October 10 from 13:00 to 13:25 CEST.
Pagani, I. (Speaker)
2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Partnerships for Impact: establishing and delivering responsive, integrated EBHC evidence and interventions in a pandemic
Miller, C. (Invited speaker)
19 May 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
COVID-19: A Public Health Response
Miller, C. (Invited speaker)
15 Feb 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
The Impact of Intermittent Fasting on Health, Aging, and Disease
Heilbronn, L. (Invited speaker)
21 Jun 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
16th Troina Meeting on Genetics of Neurodevelopmental Disorders
Gecz, J. (Invited speaker)
2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Considerations for Genome Editing in Neurological Disorders
Gecz, J. (Speaker)
2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Genetics and Biology of neurodevelopmental disabilities.
Gecz, J. (Invited speaker)
2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
PCDH19 Clustering Epilepsy
Gecz, J. (Keynote speaker)
2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
COVID-19 and Obesity: implications for policy in Asia and Oceania
Miller, C. (Invited speaker)
6 Apr 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Pandemics & syndemics - COVID-19, NCDs and the drivers of health
Miller, C. (Invited speaker)
10 May 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Genetic Epilepsy Team Australia on Precision Medicine in Epilepsy
Gecz, J. (Invited speaker)
2021 → …Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Japan Paediatric Genetics Society Annual Scientific Meeting
Gecz, J. (Keynote speaker)
2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Circadian influences on weight and metabolic health
Heilbronn, L. (Invited speaker)
3 Sept 2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Targeting Oxidative phosphorylation to eradicate chronic myeloid leukaemia stem cells
Pagani, I. (Speaker)
2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
iCMLf Conversation: CML Highlights of EHA
Pagani, I. (Speaker)
2021Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
A systems immunology approach to investigate the influence of the gut microbiota on immune responses to vaccination
Lynn, D. (Speaker)
12 Nov 2020Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Variable clinical and molecular expressivity of PCDH19 X-linked Clustering Epilepsy, a complex disorder of cellular mosaics.
Gecz, J. (Invited speaker)
2020Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
The role of epiphenotyping in epilepsy
Gecz, J. (Invited speaker)
2020Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations
-
Genomics and Aboriginal Health: Hope or Hype?
Brown, A. (Speaker)
23 Jan 2020Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations